FISEX
Price
$31.72
Change
-$0.02 (-0.06%)
Updated
Jun 5 closing price
Net Assets
4.12B
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

FISEX vs RMEBX

Header iconFISEX vs RMEBX Comparison
Open Charts FISEX vs RMEBXBanner chart's image
Franklin Equity Income A
Price$31.72
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets4.12B
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
FISEX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FISEX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FISEX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. FISEX (4.12B). FISEX pays higher dividends than RMEBX: FISEX (2.15) vs RMEBX (1.16). FISEX was incepted earlier than RMEBX: FISEX (37 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than FISEX (0.84). RMEBX (31.00) and FISEX (29.71) have comparable annual turnover. RMEBX has a lower initial minimum investment than FISEX: RMEBX (250) vs FISEX (1000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. FISEX (1.60). RMEBX return over 5 years is better than : 49.85 vs. FISEX (37.35).
FISEXRMEBXFISEX / RMEBX
Total Expense Ratio0.831.0778%
Annual Report Gross Expense Ratio0.841.0779%
Fund Existence37 years11 years-
Gain YTD1.9965.34937%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.12B105B4%
Annual Yield % from dividends2.151.16186%
Returns for 1 year1.608.3019%
Returns for 3 years13.0217.9672%
Returns for 5 years37.3549.8575%
Returns for 10 years52.7568.2177%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA